Quercetin, kaempferol and to a lesser extent rutin have been reported to have antidiabetic activities when assessed by various assay models including in vitro α-glucosidase inhibition studies. A related structural analogue, kaempferol-3-O-rutinoside (KR) however has not yet been studied for such biological effects. It was found that KR is a potent inhibitor of α-glucosidase in vitro with over 8-times more activity than the reference antidiabetic drug, acarbose. Furthermore, KR displayed a synergistic effect with a less potent flavonoid aglycones, kaempferol and quercetin. The structure-activity profile of these drugs and implications of drug combinations are discussed.
Diabetes is one of the most commonly known metabolic disorders and is caused by either inherited and/or acquired deficiency in insulin secretion or due to decreased responsiveness of organs to insulin. Inevitably, such a deficiency results in a high level of blood glucose that could lead to a variety of illnesses including heart disease, stroke, kidney failure, blindness, limb amputations and birth defects [1] . The World Health organisation (WHO) estimates that around 220 million people in the world are living with diabetes today [1] and the current figure for the UK alone is over 2.8 million [2] . One of the common approaches for the treatment of diabetes is decreasing the postprandial hyperglycemia by inhibiting the key enzymes for hydrolysis of carbohydrates in the small intestine. Hence, α-glucosidase enzyme has been the target of many antidiabetic drugs such as acarbose [3, 4] . In view of finding a more potent enzyme inhibitors with less adverse effects, research in many laboratories worldwide are currently focusing on the search of novel drugs from various sources including natural products.
Flavonoids are a large group of phenolic plant constituents with over 6000 known to be characterized so far. Quercetin (QU; Figure 1 ) is by far the most well studied flavonoids with its multifunctional biological activities widely reported in the fields of pharmacology and clinical sciences.
Literature search for QU in ScienceDirect lists over 3000 and PubMed over 7000 citations. Not surprisingly then, the antidiabetic activity of QU has been demonstrated in vivo using drug-induced experimental diabetes in rats [5, 6] . In a cellular model of antidiabetic activity study using insulin-stimulated glucose uptake in mature 3T3-L1, QU was also shown to act at multiple targets to ameliorate hyperglycemia, including by acting as partial agonists of peroxisome proliferator-activated receptor-γ [7] . Furthermore, the α-glucosidase inhibitory activity of QU in vitro has been well documented [8, 9] . The 3-O-rutinoside of QU, rutin (RT; Figure 1 ), is also a common flavonoid with somehow rather weaker α-glucosidase activity [10, 11] suggesting the adverse effect of 3-O-glycosylation in the α-glucosidase enzyme inhibition. As with QU, the close structural analogue, kaempferol (KP; Figure 1 ), has been shown to have potential antidiabetic effect when assessed in various in vitro models [7, 8] . Its 3-O-rutinoside, kaempferol-3-O-rutinoside (KR, Figure 1 ), however has not yet been studied for its potential antidiabetic effects. In the present communication, the in vitro α-glucosidase inhibitory effect of KR is assessed in comparison with its close structural analogues, KP, QU and RT. The α-glucosidase inhibitory activity of QU and KP were previously studied and potent activity was reported for both compounds, with QU slightly more potent than kaempferol [8] . This might suggest that the presence of diorthohydroxyl (catechol) functional group in the B-ring of the flavonoid skeleton is an extra-advantage for possessing anti-α-glucosidase activity. Further comparative α-glucosidase inhibitory studies revealed that rutin was far less active than its aglycone, QU [11] suggesting that O-glycosylation at C-3 position is detrimental for α-glucosidase inhibitory activity. With such literature information, the present study was designed to test the anti-α-glucosidase activity of KR through comparison with related structural analogues (KP, QU and RT). As shown in Figure 2 , KP and QU showed a concentration-dependent enzyme inhibition activity. The result shown in Figure 2 and IC 50 values ( Table 1) further revealed that QU is more potent (but not statistically significant at the level of p = 0.05) than KP as reported previously. Surprisingly, RT did not show any enzyme inhibitory activity in the present assay model up to the concentration of 250 µM.
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The activity profile of KR on α-glucosidase enzyme is shown in Figure 2 . In comparison to KP and QU, KR produced a steep concentration response curve, a profile similar with the standard antidiabetic drug, acarbose. It was astonishing to find that KR was in fact significantly (P < 0.05, unpaired t-test) more potent than both KP and QU. Hence, the structure activity relationship established in previous studies for KP, QU and RT [8, 11] does not apply for KR. It was apparent from Figure 2 and Table 1 that KR is over 8-times more potent than the standard antidiabetic drug, acarbose. The present comparative in vitro α-glucosidase inhibition studies thus clearly established KR as a strong candidate to be a possible antidiabetic agent.
Since synergistic drug interaction has been reported in αglucosidase enzyme inhibition, including between KP and QU [8] , the possible interaction of the four test compounds was also studied. For such studies, concentrations below the IC 50 values were evaluated for α-glucosidase enzyme inhibition. In agreement with previous reports, KP and QU appear to show synergistic effect as a 1:1 mixture of the compounds showed a more potent activity than the inhibitory effect of each compound alone ( Figure 3A) . It was further noticed that such synergistic drug interaction was evident between KP and KR ( Figure 3B ) as well as between QU and KR ( Figure 3C ). The two glycosides (RT and KR) do not seem to have any synergistic effect with each other ( Figure 3D ) but RT which does not have any enzyme inhibitory activity by its own at the tested concentrations, potentiate the α-glucosidase enzyme inhibitory effect of KP ( Figure 3E ) and QU ( Figure 3F ). It is thus apparent from these data that KR can also be combined with suitable flavonoid aglycones to yield a much pronounced α-glucosidase inhibition.
The present study revealed that KR is a good candidate to be studied as potential antidiabetic compound. In addition to the potent α-glucosidase enzyme inhibition by its own, KR appears to display a synergistic enzyme inhibitory effect with flavonoid aglycones, KP and QU. The use of drug combinations and plant extracts containing such bioactive compounds may be an attractive alternative approach in diabetes therapy and further studies need to focus on such rational of drug testing.
Experimental
Materials: Acarbose, yeast α-glucosidase (from Saccharomyces cerevisiae, 0.5 U/mL), kaempferol, p-nitrophenylα-D-glucopyranoside (pNPG), quercetin and rutin were purchased from Sigma (Sigma-Aldrich Chemical Company, Dorset, UK). Kaempferol-3-O-rutinoside was a product of Apin Chemicals Limited (Abingdon, UK). All other chemicals and reagents were of analytical grade and solutions were freshly prepared before use.
α-Glucosidase inhibition assay:
A microtiter-based assay was adopted. A total of 100 μL reaction mixture contained 25 μL each of 250 mM phosphate buffer (pH 6.8), 2.5 mM pNPG in the buffer, experimental drugs and 1.2 U/mL α-glucosidase. After incubation of the plates at 37°C for 10 min, 25 μL of 0.2 mol/L sodium carbonate solution was added to each well to stop the reaction. The 4-nitrophenol absorption was measured at 405 nm using solutions (1 mM) of each drug was tested in parallel with each drug alone. Multiskan plate reader (Thermo Labsystems, UK). For drug interaction studies, a 1:1 mixture from the stock solutions (1 mM) of each drug was tested in parallel with each drug alone. 
Statistical analysis:
Data are presented as mean and SEM values from a minimum of four replicates and all experiments were repeated at least three times. Where appropriate, the significance of the difference between two means was analysed by using unpaired t-test. 
